| Gallium-68-DOTA-NOC PET/CT of patients with gastroenteropancreatic neuroendocrine tumors: a prospective single-center study N Naswa, P Sharma, A Kumar, AH Nazar, R Kumar, S Chumber, C Bal American Journal of Roentgenology 197 (5), 1221-1228, 2011 | 153 | 2011 |
| 18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT S Karunanithi, P Sharma, A Kumar, BC Khangembam, ... European journal of nuclear medicine and molecular imaging 40, 1025-1035, 2013 | 113 | 2013 |
| Potential Role of 18F-FDG PET/CT in Patients With Fungal Infections P Sharma, A Mukherjee, S Karunanithi, C Bal, R Kumar American Journal of Roentgenology 203 (1), 180-189, 2014 | 97 | 2014 |
| Role of 68Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours R Kumar, P Sharma, P Garg, S Karunanithi, N Naswa, R Sharma, ... European radiology 21, 2408-2416, 2011 | 92 | 2011 |
| 18F-FDG PET-CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus? P Sharma, R Kumar, S Jeph, S Karunanithi, N Naswa, A Gupta, ... Nuclear medicine communications 32 (9), 782-788, 2011 | 87 | 2011 |
| Dual tracer functional imaging of gastroenteropancreatic neuroendocrine tumors using 68Ga-DOTA-NOC PET-CT and 18F-FDG PET-CT: competitive or complimentary? N Naswa, P Sharma, SK Gupta, S Karunanithi, RM Reddy, M Patnecha, ... Clinical Nuclear Medicine 39 (1), e27-e34, 2014 | 81 | 2014 |
| 68Ga-DOTANOC PET/CT for Baseline Evaluation of Patients with Head and Neck Paraganglioma P Sharma, A Thakar, SS KC, VS Dhull, H Singh, N Naswa, RM Reddy, ... Journal of Nuclear Medicine, 2013 | 79 | 2013 |
| F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI A Santra, R Kumar, P Sharma, C Bal, A Kumar, PK Julka, A Malhotra European journal of radiology 81 (3), 508-513, 2012 | 79 | 2012 |
| Bone scintigraphy in breast cancer: added value of hybrid SPECT-CT and its impact on patient management P Sharma, H Singh, R Kumar, C Bal, S Thulkar, V Seenu, A Malhotra Nuclear medicine communications 33 (2), 139-147, 2012 | 74 | 2012 |
| Comparative diagnostic accuracy of contrast-enhanced MRI and 18F-FDOPA PET-CT in recurrent glioma S Karunanithi, P Sharma, A Kumar, BC Khangembam, ... European radiology 23, 2628-2635, 2013 | 73 | 2013 |
| Prospective evaluation of 68Ga-DOTA-NOC PET-CT in phaeochromocytoma and paraganglioma: preliminary results from a single centre study N Naswa, P Sharma, AH Nazar, KK Agarwal, R Kumar, AC Ammini, ... European radiology 22, 710-719, 2012 | 71 | 2012 |
| PET/CT imaging of neuroendocrine tumors with 68Gallium-labeled somatostatin analogues: an overview and single institutional experience from India P Sharma, H Singh, C Bal, R Kumar Indian Journal of Nuclear Medicine 29 (1), 2-12, 2014 | 70 | 2014 |
| Fibroblast activation protein inhibitor PET/CT: a promising molecular imaging tool P Sharma, SS Singh, S Gayana Clinical nuclear medicine 46 (3), e141-e150, 2021 | 69 | 2021 |
| Comparative accuracy of CT attenuation-corrected and non–attenuation-corrected SPECT myocardial perfusion imaging P Sharma, CD Patel, S Karunanithi, S Maharjan, A Malhotra Clinical nuclear medicine 37 (4), 332-338, 2012 | 65 | 2012 |
| Somatostatin receptor based PET/CT imaging with 68Ga-DOTA-Nal3-octreotide for localization of clinically and biochemically suspected insulinoma. P Sharma, S Arora, S Karunanithi, R Khadgawat, P Durgapal, R Sharma, ... The Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official …, 2014 | 64 | 2014 |
| Pediatric nonlymphoblastic non-Hodgkin lymphoma: baseline, interim, and posttreatment PET/CT versus contrast-enhanced CT for evaluation—a prospective study S Bakhshi, V Radhakrishnan, P Sharma, R Kumar, S Thulkar, ... Radiology 262 (3), 956-968, 2012 | 64 | 2012 |
| Evaluation of 68Ga-DOTANOC PET/CT imaging in a large exclusive population of pancreatic neuroendocrine tumors P Sharma, S Arora, VS Dhull, N Naswa, R Kumar, AC Ammini, C Bal Abdominal imaging 40, 299-309, 2015 | 63 | 2015 |
| 68Ga-DOTANOC PET/CT in patients with carcinoma of unknown primary of neuroendocrine origin N Naswa, P Sharma, A Kumar, R Soundararajan, R Kumar, A Malhotra, ... Clinical nuclear medicine 37 (3), 245-251, 2012 | 62 | 2012 |
| Role of various metabolic parameters derived from baseline 18F-FDG PET/CT as prognostic markers in non–small cell lung cancer patients undergoing platinum-based chemotherapy A Sharma, A Mohan, AS Bhalla, MC Sharma, S Vishnubhatla, CJ Das, ... Clinical nuclear medicine 43 (1), e8-e17, 2018 | 61 | 2018 |
| MRI brain tumor segmentation and analysis using rough-fuzzy c-means and shape based properties A Bal, M Banerjee, A Chakrabarti, P Sharma Journal of King Saud University-Computer and Information Sciences 34 (2 …, 2022 | 59 | 2022 |
Dr. Sellam Karunanithi, MD, FANMB, F...MD (Nuclear Medicine, AIIMS, New Delhi), FANMB (Osaka, Japan), FEBNM (Barcelona, Spain)Verified email at aiims.ac.in
